Pennant price to free cash flow PNTG

Market value divided by free cash flow over the last twelve months, since 2020.

Today, Oct 23, 2026: 42.2×
6-year median: 32.7×
Against its 6-year history: 70th; percentile: 0 is its lowest day, 100 its highest
6-year range: 21.7× to 107×
Peer median: 14.7×

Pennant's price to free cash flow is 42.2× as of Oct 23, 2026.

That is above its 6-year median of 32.7×, higher than on 70% of days in the last 6 years.

Over that time it ranged from 21.7× in Jun 2026 to 107× in May 2025.

The median for 10 hospital and care facility stocks of a similar size is 14.7×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	42.2×	21.7×	42.2×
2025	27.8×	23.9×	107×
2024	57.6×	22.0×	72.3×
2023	28.7×	25.6×	47.4×
2022	n/m a value too high to mean anything
2021	25.8×	25.8×	44.1×
2020	40.2×	23.1×	43.5×

Against its peers

Companies in Medical - Care Facilities nearest Pennant's size, closest first, today.

Company	Price to free cash flow
PNTGPennant	42.2×
USPHU S Physical Therapy	20.6×
ARDTArdent Health	5.7×
HCSGHealthcare Services	11.7×
OMDAOmada Health	51.0×
PGNYProgyny	12.5×
ADUSAddus HomeCare	14.7×
MDPediatrix Medical	10.4×
PRVAPrivia Health	n/m
AVAHAveanna Healthcare	18.4×
NHCNational Healthcare	25.2×
Peer median	14.7×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Pennant

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.